Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7269) 7269
Publication (626) 626
Book Chapter (103) 103
Conference Proceeding (91) 91
Dissertation (53) 53
Book Review (46) 46
Government Document (20) 20
Magazine Article (18) 18
Book / eBook (17) 17
Web Resource (7) 7
Data Set (4) 4
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3816) 3816
index medicus (2168) 2168
mdr (1973) 1973
p-glycoprotein (1572) 1572
female (1332) 1332
animals (1278) 1278
multidrug resistance (1224) 1224
mdr-tb (1170) 1170
drug resistance (1145) 1145
male (1132) 1132
pharmacology & pharmacy (1109) 1109
tuberculosis (1039) 1039
genes, mdr (1015) 1015
infectious diseases (913) 913
oncology (851) 851
adult (850) 850
multidrug-resistance (823) 823
middle aged (743) 743
microbiology (730) 730
drug resistance in microorganisms (724) 724
cancer (689) 689
expression (685) 685
genes, mdr - genetics (629) 629
biochemistry & molecular biology (618) 618
drug resistance, multiple (610) 610
drug-resistance (556) 556
mice (539) 539
chemotherapy (527) 527
microbial sensitivity tests (520) 520
drug resistance, neoplasm (488) 488
cell line, tumor (478) 478
atp-binding cassette, sub-family b, member 1 - genetics (467) 467
tuberculosis, multidrug-resistant - drug therapy (454) 454
analysis (452) 452
aged (442) 442
atp-binding cassette, sub-family b, member 1 - metabolism (424) 424
mycobacterium tuberculosis - drug effects (420) 420
antitubercular agents - therapeutic use (419) 419
research (417) 417
antineoplastic agents - pharmacology (415) 415
tumor cells, cultured (410) 410
drug resistance, multiple - genetics (387) 387
respiratory system (381) 381
chemistry, medicinal (376) 376
mycobacterium-tuberculosis (366) 366
gene expression (362) 362
cells (355) 355
adolescent (344) 344
genotype (344) 344
in-vitro (342) 342
anti-bacterial agents - pharmacology (338) 338
immunology (336) 336
apoptosis (327) 327
mycobacterium tuberculosis (316) 316
resistance (310) 310
drugs (309) 309
doxorubicin - pharmacology (308) 308
treatment outcome (304) 304
mutation (303) 303
cell biology (300) 300
genetic aspects (300) 300
tuberculosis, multidrug-resistant - epidemiology (293) 293
drug resistance, multiple, bacterial (292) 292
gene (290) 290
genes (286) 286
prevalence (285) 285
drug therapy (284) 284
doxorubicin (282) 282
polymerase chain reaction (281) 281
risk factors (281) 281
bacteria (276) 276
drug resistance, neoplasm - genetics (275) 275
health aspects (271) 271
multidrug-resistant tuberculosis (271) 271
medicine (267) 267
antitubercular agents - pharmacology (260) 260
molecular sequence data (260) 260
proteins (250) 250
care and treatment (244) 244
xdr-tb (241) 241
epidemiology (239) 239
medicine, research & experimental (233) 233
tuberculosis, multidrug-resistant - microbiology (232) 232
article (231) 231
child (231) 231
drug resistance, multiple - drug effects (230) 230
atp-binding cassette transporters - genetics (229) 229
reverse transcriptase polymerase chain reaction (229) 229
mdr1 (228) 228
phenotype (226) 226
pulmonary tuberculosis (225) 225
base sequence (219) 219
p-glycoprotein expression (218) 218
hematology (213) 213
antibiotics (212) 212
young adult (212) 212
drug resistance, neoplasm - drug effects (210) 210
diagnosis (208) 208
antimicrobial resistance (207) 207
atp-binding cassette, sub-family b, member 1 - biosynthesis (207) 207
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7096) 7096
Chinese (173) 173
Japanese (117) 117
French (61) 61
Korean (56) 56
German (41) 41
Spanish (40) 40
Russian (25) 25
Polish (18) 18
Portuguese (18) 18
Italian (9) 9
Persian (7) 7
Turkish (5) 5
Hungarian (4) 4
Romanian (4) 4
Arabic (3) 3
Czech (3) 3
Icelandic (2) 2
Slovak (2) 2
Croatian (1) 1
Dutch (1) 1
Finnish (1) 1
Indonesian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. High cure rate with standardised short-course multidrugresistant tuberculosis treatment in Niger: No relapses
by Piubello, A and Harouna, S. Hassane and Souleymane, M.B and Boukary, I and Morou, S and Daouda, M and Hanki, Y and Van Deun, A
International Journal of Tuberculosis and Lung Disease, ISSN 1027-3719, 10/2014, Volume 18, Issue 10, pp. 1188 - 1194
SETTING: Niger National Tuberculosis Programme. Regions supported by the Damien Foundation. OBJECTIVE: To evaluate the effectiveness of a shortcourse... 
Fluoroquinolones | Niger | MDR-TB
Journal Article
Details down arrow
2. Full Text Viewpoint: Scientific dogmas, paradoxes and mysteries of latent Mycobacterium tuberculosis infection
by Zumla, Alimuddin and Atun, Rifat and Maeurer, Markus and Mwaba, Peter and Ma, Zhenkun and O’Grady, Justin and Bates, Matthew and Dheda, Keertan and Hoelscher, Michael and Grange, John
Tropical Medicine & International Health, ISSN 1360-2276, 01/2011, Volume 16, Issue 1, pp. 79 - 83
Summary Worldwide, there are nearly 10 million new cases of active TB and 1.8 million associated deaths every year. WHO estimates that one‐third of the world’s... 
tuberculose | réactivation | isoniazid | latencia | isoniazida | tuberculosis multirresistente y extremadamente resistente (MDR/XDR‐TB) | terapia preventiva | preventive therapy | tuberculosis | latency | inmunología | re‐activation | immunologie | reactivación | TB MDR/UR | latence | Mycobacterium tuberculosis | isoniazide | traitement préventif | MDR/XDR‐TB | immunology | MDR/XDR-TB | Immunology | Tuberculosis | Preventive therapy | Re-activation | Isoniazid | Latency | LUNG-TISSUE | reactivacion | MULTIDRUG-RESISTANT | reactivation | traitement preventif | TROPICAL MEDICINE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | MDR | TB MDR | inmunologia | tuberculosis multirresistente y extremadamente resistente (MDR | XDR-TB | re-activation | Host-Pathogen Interactions | Evidence-Based Medicine - methods | Global Health | Latent Tuberculosis - therapy | Humans | Latent Tuberculosis - epidemiology | Terminology as Topic | Isoniazid - therapeutic use | Latent Tuberculosis - microbiology | Antitubercular Agents - therapeutic use | Medical colleges | International cooperation | Antitubercular agents | Health aspects | Medicine, Preventive | Preventive health services
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Shorter regimens for multidrug-resistant tuberculosis should also be applicable in Europe
by Heldal, E and Van Deun, A and Chiang, CY and Rieder, HL
EUROPEAN RESPIRATORY JOURNAL, ISSN 0903-1936, 06/2017, Volume 49, Issue 6
RESPIRATORY SYSTEM | MDR-TB
Journal Article
Details down arrow
4. Full Text Pharmacokinetics of second-line antituberculosis drugs in children with multidrug-resistant tuberculosis in India
by Kumar, Agibothu Kupparam Hemanth and Kumar, Alok and Kannan, Thiruvengadam and Bhatia, Rakesh and Agarwal, Dipti and Kumar, Santosh and Dayal, Rajeshwar and Singh, Sheo Pratap and Ramachandran, Geetha
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 05/2018, Volume 62, Issue 5
MDR-TB | Children | Pharmacokinetics | India
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Is Severe and Long-lasting Linezolid-induced Optic Neuropathy Reversible?
by Lee, Seul and Kang, Bo Hyoung and Ryu, Won Yeol and Um, Soo Jung and Roh, Mee Sook and Son, Choonhee
Internal Medicine, ISSN 0918-2918, 2019
Linezolid is a useful drug for treating drug-resistant tuberculosis. However, the associated toxicities, especially optic neuritis, are a major obstacle for... 
MDR-TB | neuropathy | linezolid
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Multi drug resistant female genital tuberculosis: A preliminary report
by Sharma, J.B and Kriplani, Alka and Sharma, Eshani and Sharma, Sangeeta and Dharmendra, Sona and Kumar, Sunesh and Vanamail, P and Sharma, S.K
European Journal of Obstetrics & Gynecology and Reproductive Biology, ISSN 0301-2115, 2016, Volume 210, pp. 108 - 115
Abstract Objective Evaluation of 6 patients presenting with tubo-ovarian mass or infertility with multi drug resistant (MDR) female genital tuberculosis... 
Obstetrics and Gynecology | Primary MDR FGTB | Female genital tuberculosis | MDR TB | Anti-tuberculous therapy | Disseminated disease | Secondary MDR FGTB | Secondary MDR | Primary MDR | WOMEN | REPRODUCTIVE BIOLOGY | ASSAY | XPERT MTB/RIF | OBSTETRICS & GYNECOLOGY | Prospective Studies | Tuberculosis, Female Genital - epidemiology | Humans | India - epidemiology | Genitalia, Female - pathology | Tuberculosis, Multidrug-Resistant - epidemiology | Tuberculosis, Female Genital - pathology | Adolescent | Tuberculosis, Female Genital - drug therapy | Adult | Female | Tuberculosis, Multidrug-Resistant - pathology | Antitubercular Agents - therapeutic use | Tuberculosis, Multidrug-Resistant - drug therapy | Respiratory tract diseases | Antitubercular agents | Tuberculosis | Drug resistance | Drug therapy | Aminosalicylic acids | Rifampin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Chemotherapy of osteoarticular tuberculosis
by Hazra, Avijit and Laha, Baisakhi
Chemotherapy of osteoarticular tuberculosis, 12/2005
Tuberculosis (TB) of the bones and joints is rampant in India with the dorsolumbar spine as the most common site of osseous involvement. For diagnosis,... 
Bone tuberculosis, caries spine, antitubercular drugs, MDR-TB
Journal
Details down arrow
8. Full Text Current treatment of multidrug resistant tuberculosis in Ethiopia: An aggregated and individual patients' data analysis for outcome and effectiveness of the current regimens 11 Medical and Health Sciences 1117 Public Health and Health Services
by Eshetie, Setegn and Alebel, Animut and Wagnew, Fasil and Geremew, Demeke and Fasil, Alebachew and Sack, Ulrich
BMC Infectious Diseases, 09/2018, Volume 18, Issue 1
MDR-TB | Ethiopia | Treatment success
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Targeting vincristine plus tetrandrine liposomes modified with DSPE-PEG2000-transferrin in treatment of brain glioma
by Song, Xiao-li and Liu, Shuang and Jiang, Ying and Gu, Li-yan and Xiao, Yao and Wang, Xin and Cheng, Lan and Li, Xue-tao
European Journal of Pharmaceutical Sciences, ISSN 0928-0987, 01/2017, Volume 96, pp. 129 - 140
Glioma is the most frequent primary tumor, and the treatment efficiency is unsatisfactory for the obstacle of the blood brain barrier (BBB), the multidrug... 
Transferrin | Tetrandrine | MDR | BBB | Vincristine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text MFS transporters required for multidrug/multixenobiotic (MD/MX) resistance in the model yeast: Understanding their physiological function through post-genomic approaches
by dos Santos, Sandra C and Teixeira, Miguel C and Dias, Paulo J and Sá-Correia, Isabel
Frontiers in Physiology, ISSN 1664-042X, 2014, Volume 5, p. 180
Multidrug/Multixenobiotic resistance (MDR/MXR) is a widespread phenomenon with clinical, agricultural and biotechnological implications, where MDR/MXR... 
Phylogenetic analysis | MDR/MXR transporters | Genome-wide approaches | Multidrug/multixenobiotic resistance (MDR/MXR) | Major Facilitator Superfamily (MFS) | Transcriptional regulation | Saccharomyces cerevisiae | PROTEIN LOCALIZATION | PHYSIOLOGY | transcriptional regulation | multidrug/multixenobiotic resistance (MDR/MXR) | genome-wide approaches | MAJOR FACILITATOR SUPERFAMILY | DRUG-RESISTANCE | ACETIC-ACID | phylogenetic analysis | NATURAL TOXIC COMPOUNDS | CANDIDA-ALBICANS GENE | SACCHAROMYCES-CEREVISIAE RESPONSE | MULTIDRUG-RESISTANCE | KLUYVEROMYCES-LACTIS | OXIDATIVE STRESS-RESPONSE | Multidrug/Multixenobiotic resistance (MDR/MXR)
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text CURRENT CONCEPTS Tuberculosis
by Zumla, A and Raviglione, M and Hafner, R and von Reyn, CF
NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 02/2013, Volume 368, Issue 8, pp. 745 - 755
DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | EFFICACY | REINFECTION | MULTIDRUG-RESISTANT TUBERCULOSIS | PREVENTION | RISK | ANTIRETROVIRAL THERAPY | MDR | OUTCOMES | HIV-INFECTED ADULTS
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Perspectives for personalized therapy for patients with multidrug‐resistant tuberculosis
by Lange, C and Alghamdi, W. A and Al‐Shaer, M. H and Brighenti, S and Diacon, A. H and DiNardo, A. R and Grobbel, H. P and Gröschel, M. I and Groote‐Bidlingmaier, F and Hauptmann, M and Heyckendorf, J and Köhler, N and Kohl, T. A and Merker, M and Niemann, S and Peloquin, C. A and Reimann, M and Schaible, U. E and Schaub, D and Schleusener, V and Thye, T and Schön, T and Medicinska fakulteten and Linköpings universitet and Institutionen för klinisk och experimentell medicin and Avdelningen för mikrobiologi och molekylär medicin
Journal of Internal Medicine, ISSN 0954-6820, 08/2018, Volume 284, Issue 2, pp. 163 - 188
According to the World Health Organization (WHO), tuberculosis is the leading cause of death attributed to a single microbial pathogen worldwide. In addition... 
MDR‐TB | XDR‐TB | individualized medicine | personalized medicine | MDR-TB | XDR-TB | PARA-AMINOSALICYLIC ACID | MYCOBACTERIUM-TUBERCULOSIS | LIMITED SAMPLING STRATEGY | DRUG-RESISTANT | MEDICINE, GENERAL & INTERNAL | HOST-DIRECTED THERAPIES | RECONSTITUTION INFLAMMATORY SYNDROME | POPULATION PHARMACOKINETICS | PULMONARY TUBERCULOSIS | MINIMUM INHIBITORY CONCENTRATIONS | Drug resistance in microorganisms | Care and treatment | Tuberculosis | Rifampin | Therapy | Microorganisms | Isoniazid | Patients | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | General Practice | Allmänmedicin | Klinisk medicin | individualized medicine; MDR-TB; personalized medicine; XDR-TB
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Inhibition of acrb efflux pump in multidrug-resistant gram-negative bacteria by herbal extracts
by Tilton, Florida and Shanmughasundar, D and Nair, Aneesh and Bindu, D and Saikumar, Chitralekha and Johnson, W.M.S
International Journal of Research in Pharmaceutical Sciences, 10/2018, Volume 9, Issue 4, pp. 1452 - 1456
MDR | AcrAB | E.coli | EPI
Journal Article
Details down arrow
14. Full Text Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents
by Jia, Hui and Yang, Qian and Yang, Yong-ping and Wang, Tao and Cao, Yu and Jiang, Qi-yu and Ma, Hong-da and Sun, Hui-wei and Hou, Ming-xiao and Feng, Fan
BBA - General Subjects, ISSN 0304-4165, 07/2016, Volume 1860, Issue 7, pp. 1417 - 1430
The rapid development of multi-drug resistance (MDR) process has hindered the effectiveness of advanced hepatocellular carcinoma (HCC) treatments. Notch-1... 
Rhamnetin | MDR-related proteins | HCC | MDR | MiR-34a | Notch-1 pathway | MIR-34a | PROTEIN PROMOTES PROLIFERATION | APOPTOSIS | METASTASIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | DOWN-REGULATION | SORAFENIB | EPITHELIAL-MESENCHYMAL TRANSITION | INVASION | BIOPHYSICS | PATHWAY | GROWTH | MULTIDRUG-RESISTANCE | Chemotherapy | Hepatoma | Drug resistance | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Potent ß-lactam enhancer activity of zidebactam and WCK 5153 against Acinetobacter baumannii, including carbapenemase-producing clinical isolates
by Moya, Bartolome and Barcelo, Isabel M and Bhagwat, Sachin and Patel, Mahesh and Bou, German and Papp-Wallace, Krisztina M and Bonomo, Robert A and Moya, Bartolome
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 11/2017, Volume 61, Issue 11
MDR A. baumannii | Zidebactam | lactam enhancer | PBP IC50 | WCK 5153
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance
by Creixell, Mar and Peppas, Nicholas A
Nano Today, ISSN 1748-0132, 08/2012, Volume 7, Issue 4, pp. 367 - 379
► Efflux pumps and apoptotic pathways are the two main mechanisms of cell cancer resistance. ► Nanotechnology helps antineoplastic drugs bypass efflux pumps,... 
Nanoparticles | Co-delivery | siRNA | Multi drug resistance (MDR) | Doxorubicin | Cancer therapy | EFFICIENT DELIVERY | LIPID NANOPARTICLES | SMALL-INTERFERING RNA | DRUG-DELIVERY | MATERIALS SCIENCE, MULTIDISCIPLINARY | MESOPOROUS SILICA NANOPARTICLES | ANTICANCER DRUG | NANOSCIENCE & NANOTECHNOLOGY | Multi drug resistance | CHEMISTRY, MULTIDISCIPLINARY | P-GLYCOPROTEIN | MDR | POLYMER NANOPARTICLES | MULTIDRUG-RESISTANCE | TUMOR-GROWTH | Care and treatment | Drug resistance | Health aspects | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights